New research suggests that patients who discontinue new weight-loss injections like Wegovy and Mounjaro may regain shed pounds far faster than those who halt traditional diet and exercise plans.
Research printed in a leading health publication demonstrates that while obese individuals often shed substantial amounts of their total mass while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"Users purchasing these medications must be aware of the potential of rapid rebound weight gain when the therapy ends," stated expert Dr. Susan Jebb.
Such speed of recovery implies a reversion to pre-treatment weight within about a year and a half.
Analyzing Treatments
The research, which examined dozens of trials involving thousands of patients, contrasted the results of the injectable medications with older methods.
The team emphasize that individuals who lose weight through dieting usually see a slower weight regain—around 100 grams monthly—after stopping.
The Reason for the Quick Rebound
Experts propose the mode of action of the drugs explains the amplified weight return.
GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Artificially providing GLP-1 levels far above than the body's typical production could lead to the body to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics expert.
"Withdrawal of this hormone supplement means hunger is uncontrolled, making overeating far more likely."
An Ongoing Condition?
The NHS recommend the jabs for individuals with obesity-related health risks, accompanied by recommended lifestyle changes.
Professionals argue that, given the likelihood of weight regain, the therapy might need to be ongoing.
This perspective is echoed by drug manufacturers, who say that the findings "underscore the persistent character of obesity," akin to managing diseases like diabetes.
User Testimonies
Users who have come off the medication report a intense resurgence of cravings.
"It was like something that goes on and you're instantly extremely hungry," recalled an individual.
This difficulty is worsened if individuals have not developed sustainable lifestyle or habit modifications during treatment.
Significant Adoption
Survey data indicate that millions of people in the UK have used weight-loss jabs in the past year, with desire remaining high.
- Use is greater among females than males.
- The middle-aged age group shows the greatest usage rates.
- Many access the medications through private healthcare rather than the NHS.
In conclusion, clinicians emphasize that while these medications are effective tools for weight loss, they are not a permanent fix and maintained weight loss hinges on ongoing behavioural changes.
